v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 2,840 $ 898 $ 4,500 $ 1,408
General and administrative 1,610 684 3,746 1,396
Total operating expenses 4,450 1,582 8,246 2,804
Loss from operations (4,450) (1,582) (8,246) (2,804)
Other expense, net 52 309 10 796
Net loss $ (4,502) $ (1,891) $ (8,256) $ (3,600)
Net loss per share, basic $ (0.66) $ (5.45) $ (1.48) $ (10.39)
Net loss per share, diluted $ (0.66) $ (5.45) $ (1.48) $ (10.39)
Weighted average number of shares of common stock and pre-funded warrants used in computing net loss per share, basic 6,789,165 347,000 5,592,596 346,482
Weighted average number of shares of common stock and pre-funded warrants used in computing net loss per share, diluted 6,789,165 347,000 5,592,596 346,482